The Oread Angels returns this summer with a focused afternoon of insight, connection, and curated deal flow—this time at the University of Kansas Medical Center’s Health Education Building in Kansas City.

On Tuesday, June 16, beginning at 1 p.m., investors and founders will gather for a program anchored by a featured talk from Matthias A. Salathe, a physician and scientist whose work sits at the intersection of pulmonary medicine, research, and innovation. His perspective will set the stage for an afternoon centered on translating breakthrough ideas into real-world impact.

Why attend: In addition to hearing from emerging companies connected to the University of Kansas ecosystem and beyond, attendees will gain insight into the role angel investment can play in advancing healthcare innovation. For physicians and healthcare leaders, the event offers a unique opportunity to see promising startups being built within the regional innovation community, connect directly with founders tackling real clinical and operational challenges, and explore how their expertise, perspective, and investment can help shape the future of healthcare innovation.

Please note: this invite is by invitation only. If you received this link to register, please RSVP below by Friday, June 12.

The event will also feature showcases from several high-potential companies, offering Oread Angels members a front-row seat to emerging opportunities connected to the University of Kansas ecosystem and beyond. As always, the program is designed to spark meaningful investment conversations while strengthening relationships across the network.

Showcase companies include:

• Love Lifesciences, whose flagship innovation, UNIPEN, is the first therapeutic-agnostic injection system designed to optimize efficiency, safety, and precision across a diverse range of therapies.
• Phoreus Biotech, which is developing next-generation Peptide Nanoparticles (PNPs) to address longstanding drug delivery challenges.
• Vytas Bio, which is developing laboratory-derived tests (LDTs) and clinical in vitro diagnostic (cIVD) tests for earlier cancer detection through exosomes-based liquid biopsy.
• Enhance Health, which is transforming how chronic liver and kidney disease are managed by enabling continuous, at-home organ health monitoring. 

Networking will be woven throughout the afternoon, creating space for connection among investors, founders, and partners who are actively shaping the region’s innovation economy.

The full agenda and company details will be shared soon.

Event Details
Tuesday, June 16 at 1 p.m.
KU Medical Center Health Education Building’s Ad Astra room
2160 W. 39th Ave., Kansas City, KS

Thanks to our partners for their support of this event.

Logistics

• Ad Astra is on the fifth floor of the Health Education Building (HEB) on the corner of 39th and Rainbow.
• Guests should enter through the main lobby, where signage and staff will help direct you to the event space.
• Additional details on parking, directions, and day-of access will be shared with registered attendees in advance of the event.